Abbott’s Mylan Billions Open Door for Bigger Purchases: Real M&A

Updated on

Mylan NV’s three-way deal drama is putting the spotlight on a fourth player: Abbott Laboratories.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.